Results 31 to 40 of about 710,167 (255)

Sugammadex to reverse neuromuscular blockade in a child with a past history of cardiac transplantation

open access: yesAnnals of Cardiac Anaesthesia, 2017
Sugammadex is a novel agent for the reversal of neuromuscular blockade. The speed and efficacy of reversal with sugammadex are significantly faster than acetylcholinesterase inhibitors, such as neostigmine.
Karen Miller   +2 more
doaj   +1 more source

Ligands affinity for regulatory sites of human acetylcholesterase and butyrylcholinesterase: A comparative bioinformatic analysis

open access: yesУчёные записки Казанского университета: Серия Естественные науки, 2021
Cholinesterase inhibitors have been the subject of many studies aimed at developing an effective treatment for various cognitive disorders. Therefore, studying cholinesterases and elucidating the mechanism of their interaction with ligands provide a ...
A.R. Mukhametgalieva   +3 more
doaj   +1 more source

Intranasal administration of acetylcholinesterase inhibitors [PDF]

open access: yesBMC Neuroscience, 2008
This short review outlines the rationale, challenges, and opportunities for intranasal acetylcholinesterases, in particular galantamine. An in vitro screening model facilitated the development of a therapeutically viable formulation. In vivo testing confirmed achievement of therapeutically relevant drug levels that matched or exceeded those for oral ...
Costantino, Henry R   +4 more
openaire   +2 more sources

Revealing the Acetylcholinesterase Inhibitory Potential of and Its Phytoconstituents: In Vitro and in Silico Approach

open access: yesBioinformatics and Biology Insights, 2022
The inhibition of acetylcholinesterase plays a vital role in the treatment of Alzheimer disease. This study aimed to explore the acetylcholinesterase inhibition potential of Phyllanthus amarus and its phytoconstituents through an in vitro and in silico ...
Kolade O Faloye   +10 more
doaj   +1 more source

Sugammadex and recurarization in an infant. [PDF]

open access: yesPediatric Anesthesia and Critical Care Journal (PACCJ), 2020
Sugammadex is a novel pharmacologic agent, which re- verses neuromuscular blockade via a mechanism that dif- fers completely from acetylcholinesterase inhibitors such as neostigmine.
J. Arends, J. D. Tobias
doaj   +1 more source

Identification of Potential Herbal Inhibitor of Acetylcholinesterase Associated Alzheimer’s Disorders Using Molecular Docking and Molecular Dynamics Simulation [PDF]

open access: yes, 2014
Cholinesterase inhibitors (ChE-Is) are the standard for the therapy of AD associated disorders and are the only class of approved drugs by the Food and Drug Administration (FDA).
Kuldeep Uchadia   +5 more
core   +1 more source

Using Virtual AChE Homology Screening to Identify Small Molecules With the Ability to Inhibit Marine Biofouling

open access: yesFrontiers in Marine Science, 2021
The search for effective yet environmentally friendly strategies to prevent marine biofouling is hampered by the large taxonomic diversity amongst fouling organisms and a lack of well-defined conserved molecular targets.
Homayon John Arabshahi   +7 more
doaj   +1 more source

Biallelic PIGB Variants Cause Motor Neuropathy with Conduction Blocks and Peripheral Nerve Hyperexcitability

open access: yesAnnals of Neurology, EarlyView.
Objective Glycosylphosphatidylinositol (GPI)‐anchored proteins play critical roles in nervous system function. Pathogenic variants in genes involved in GPI‐anchor biosynthesis cause early‐onset multisystem disorders known as inherited GPI deficiencies. We describe a novel neuromuscular phenotype associated with PIGB deficiency.
Gorka Fernández‐Eulate   +34 more
wiley   +1 more source

Acetylcholinesterase Inhibitors [PDF]

open access: yesThe Primary Care Companion For CNS Disorders, 2000
Sir: Behavioral disturbances are seen in up to 90% of patients with Alzheimer' type dementia at some point during the illness.1,2 There is evidence that cholinesterase inhibitors may help in controlling dementia associated behavioral disturbances.3–5 We present a case report of a patient with behavioral disturbance associated with severe Alzheimer ...
Sanjay, Gupta   +2 more
openaire   +2 more sources

Synthesis, Molecular Modelling and Biological Evaluation of Novel Heterodimeric, Multiple Ligands Targeting Cholinesterases and Amyloid Beta

open access: yesMolecules, 2016
Cholinesterases and amyloid beta are one of the major biological targets in the search for a new and efficacious treatment of Alzheimer’s disease. The study describes synthesis and pharmacological evaluation of new compounds designed as dual binding site
Michalina Hebda   +10 more
doaj   +1 more source

Home - About - Disclaimer - Privacy